Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan C Homans

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pediatric Blood & Cancer|September 13, 2005
Cyclophosphamide disposition in an anephric childJeannine S McCune, Denise Adams, Alan C Homans, et al.
Journal of Pediatric Hematology/Oncology|September 3, 2004
Topotecan disposition in an anephric childLisa C Iacono, Denise Adams, Alan C Homans, et al.
Pediatric Blood & Cancer|September 27, 2018
Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumabAlissa A Thomas, Suzanne M Tucker, Carl J Nelson, et al.
Journal of Pediatric Hematology/Oncology|November 11, 2010
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastomaGiselle L Saulnier Sholler, Genevieve M Bergendahl, Laurent Brard, et al.
Nature Medicine|June 23, 2022
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancerAlanna J Church, Laura B Corson, Pei-Chi Kao, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pediatric Blood & Cancer|September 13, 2005
Cyclophosphamide disposition in an anephric childJeannine S McCune, Denise Adams, Alan C Homans, et al.
Journal of Pediatric Hematology/Oncology|September 3, 2004
Topotecan disposition in an anephric childLisa C Iacono, Denise Adams, Alan C Homans, et al.
Pediatric Blood & Cancer|September 27, 2018
Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumabAlissa A Thomas, Suzanne M Tucker, Carl J Nelson, et al.
Journal of Pediatric Hematology/Oncology|November 11, 2010
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastomaGiselle L Saulnier Sholler, Genevieve M Bergendahl, Laurent Brard, et al.
Nature Medicine|June 23, 2022
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancerAlanna J Church, Laura B Corson, Pei-Chi Kao, et al.
Pageof 1